Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-09
1995-03-28
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548183, C07D41714, A61K 31425
Patent
active
054017610
ABSTRACT:
Compounds of the formula ##STR1## where R is alkyl, cycloalkyl, phenyl or substituted phenyl are useful as hypoglycemic agents.
REFERENCES:
patent: 4332952 (1982-06-01), Schnur
patent: 4340605 (1982-07-01), Kawamatsu et al.
patent: 4342771 (1982-08-01), Schnur
patent: 4367234 (1983-01-01), Schnur
patent: 4617312 (1986-10-01), Schnur
patent: 4703052 (1987-10-01), Eggler et al.
patent: 4725610 (1988-02-01), Meguro et al.
Shoda (Chem. Pharm. Bull, 30, 3580 (1982)).
Goldstein Steven W.
Hulin Bernard
Benson Gregg C.
Brokke Mervin E.
Gerstl Robert
Pfizer Inc.
Richardson Peter C.
LandOfFree
Thiazolidinedione hypoglycemic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiazolidinedione hypoglycemic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidinedione hypoglycemic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2250863